Thursday, January 26 | 12-1 p.m. ET | Virtual
The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and basic sciences.
Shelley Hwang, MD, MPH
Mary and Deryl Hart Distinguished Professor of Surgery
Professor of Radiology
Duke Department of Surgery
Learn more and register on the forum series website.
Thursday, January 12 | 12-1 p.m. ET | Virtual
The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and basic sciences.
Sara Imhof, PhD
Senior Director, Precision Health
North Carolina Biotechnology Center
Title: NC Leadership in Precision Health: Highlights in and around RTP
Learn more and register on the forum series website.
Thursday, December 15 | 9 a.m. ET | Virtual
This webinar will be presented by Dr. Peter Würtz and Dr. Jeffrey Barrett. The title of their talk is “Nightingale Biomarker Profiling Across Large Biobanks – From Molecular Insights to Advancing Preventative Health Screening.”
To learn more about the guest speakers and webinar, please visit the IHCC Educational Webinar Series webpage.
Please note: Registration is required for this event.
Muin J Khoury, Scott Bowen, W David Dotson, Emily Drzymalla, Ridgely F Green, Robert Goldstein, Katherine Kolor, Leandris C Liburd, Laurence S Sperling, Rebecca Bunnell
Abstract
Recent reviews have emphasized the need for a health equity agenda in genomics research. To ensure that genomic discoveries can lead to improved health outcomes for all segments of the population, a health equity agenda needs to go beyond research studies. Advances in genomics and precision medicine have led to an increasing number of evidence-based applications that can reduce morbidity and mortality for millions of people (tier 1). Studies have shown lower implementation rates for selected diseases with tier 1 applications (familial hypercholesterolemia, Lynch syndrome, hereditary breast and ovarian cancer) among racial and ethnic minority groups, rural communities, uninsured or underinsured people, and those with lower education and income. We make the case that a public health agenda is needed to address disparities in implementation of genomics and precision medicine. Public health actions can be centered on population-specific needs and outcomes assessment, policy and evidence development, and assurance of delivery of effective and ethical interventions. Crucial public health activities also include engaging communities, building coalitions, improving genetic health literacy, and building a diverse workforce. Without concerted public health action, further advances in genomics with potentially broad applications could lead to further widening of health disparities in the next decade.
Keywords: Genomics; Health equity; Precision medicine; Public health genomics.
Monday, November 7 | 10 am-12 pm | Virtual
Join the UNC Program for Precision Medicine in Health Care (PPMH) for Biomedical Imaging for Precision Diagnosis, Prognosis, and Therapy, a free virtual mini-symposium. Precision medicine harnesses genomic sequence data to provide prediction of disease risk and choice of optimum treatment. Biomedical imaging is an integral part of early diagnosis and individually tailored treatment. The speakers at this mini-symposium will address data-driven approaches to developing personalized treatment strategies.
Presentations:
Longitudinal neuroimaging to study the brain development of infants with neurodevelopmental disorders
Mark Shen, PhD
Assistant Professor of Psychiatry & Neuroscience, Carolina Institute for Developmental Disabilities, UNC School of Medicine
AI-based stratification of progression along the Alzheimer disease continuum
Eran Dayan, PhD
Associate Professor, Department of Radiology
A living ex vivo platform for functional, personalized brain cancer diagnosis
Andrew Satterlee, PhD
Brain Slice Technology Program Manager, Eshelman Institute for Innovation, Eshelman School of Pharmacy
Learn more about the presentations and register for the symposium on the PPMH website.
Wednesday, October 12, 2022 | 10:30 am – 6 pm ET | Virtual
A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop to examine how genomic data are used in health care settings and to identify opportunities for advancement of precision health care delivery. The overarching goal of the workshop is to examine strategies to ensure that genomic applications are responsibly and equitably adopted to benefit populations as well as individuals over time.
Learn more about the workshop on the NASEM website.
October 25-29 | Los Angeles, CA
ASHG 2022 will take place October 25-29 in Los Angeles. The meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. ASHG members and leading scientists from around the world are selected to present their research findings at invited, plenary, platform, and poster sessions. This year’s meeting will be an unmatched opportunity to reunite and reconnect with your colleagues in a warm, diverse, and welcoming city. The official meeting language is English.
Registration is required and fees vary. Visit the ASHG website for more details about the conference.
Thursday, September 29 | 9 am EST | Virtual
This webinar will be presented by Dr. Nahla Maher Afifi. The title of her talk is “Qatar Biobank: A Pillar in Precision Medicine Initiative.”
To learn more about the guest speaker and webinar, please visit the IHCC Educational Webinar Series webpage.
Please note: Registration is required for this event.
Updates in Precision Medicine: Pharmacogenomics and Pharmacovigilance Conference
Wednesday, September 28 – Thursday, September 29, 2022 | Orlando, FL & Online
This conference, co-hosted by the University of Florida College of Pharmacy and GenomeWeb’s Precision Medicine Leaders’ Summit, will highlight the evolving role of molecular profiling in pharmacology – from new developments in pharmacogenomics to emerging biomarker strategies for post-market surveillance. Join other clinicians, researchers, and thought leaders from medicine and pharmacy to hear from expert speakers with experience implementing genomic medicine and pharmacogenomics in a variety of settings.
Learn more and register on the conference website.
Note: Registration fees vary and will increase after August 15. IGNITE members can use promo code IGNITE to register at a reduced rate.
From All of Us Research to All of Us in the Real World: Using the All of Us Research Program Data to Improve Population Health
Thursday, September 29 | 9:30-11 a.m., ET | Virtual | Free, registration required
Through a Data Use Agreement with the All of Us Research Program, scientists at the Centers for Disease Control and Prevention can now register to access and analyze All of Us Research Program Data through a cloud platform. In this seminar we will: 1) Review the All of Us Research Program study design and current status, 2) Discuss its potential for providing important population data to inform implementation of disease prevention and to reduce health disparities and 3) Provide a hands-on training session for scientists interested in accessing and analyzing All of Us Data.
GMKB